The Anti-Inflammatory Compound Lisofylline Prevents Type I Diabetes in Non-Obese Diabetic Mice
Diabetologia - Germany
doi 10.1007/s00125-002-0901-y
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2002
Authors
Publisher
Springer Science and Business Media LLC